1987
DOI: 10.1016/0006-8993(87)90187-9
|View full text |Cite
|
Sign up to set email alerts
|

Development of an anti-idiotypic antibody that blocks substance P primary antibodies and substance P membrane binding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1989
1989
1996
1996

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The second approach involves the use of antiidiotypic antibodies. The latter have already been developed against thyroid-stimulating hormone, thyrotropin, insulin, vasopressin, prolactin, substance P, and opioid and dopamine receptors (Sege and Peterson, 1978;Schreiber et al, 1980;Farid et al, 1982;Homcy el al., 1982;Guillet et al, 1984;Shechter et al, 1984;Couraud et al, 1985;Farid, 1985;Ng and Isom, 1985;Amit et al, 1986;Knigge et al, 1987;Swenberg et al, 1987;Hassan et al, 1989;Strosberg, 1989;Mons et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…The second approach involves the use of antiidiotypic antibodies. The latter have already been developed against thyroid-stimulating hormone, thyrotropin, insulin, vasopressin, prolactin, substance P, and opioid and dopamine receptors (Sege and Peterson, 1978;Schreiber et al, 1980;Farid et al, 1982;Homcy el al., 1982;Guillet et al, 1984;Shechter et al, 1984;Couraud et al, 1985;Farid, 1985;Ng and Isom, 1985;Amit et al, 1986;Knigge et al, 1987;Swenberg et al, 1987;Hassan et al, 1989;Strosberg, 1989;Mons et al, 1991).…”
Section: Introductionmentioning
confidence: 99%